Table 1.
Patient 1 | Patient 2 | Reference Range | |
---|---|---|---|
BMI (kg/m2) | 26.2 | 27.3 | 18.5–25 |
Total cholesterol (mmol/L) | 16.81 | 10.88 | |
HDL cholesterol (mmol/L) | 1.53 | 2.00 | |
LDL cholesterol (mmol/L) | 15.02 | 8.59 | |
Triglycerides (mmol/L) | 0.57 | 0.65 | <1.80 |
ApoB (mg/dL) | 321 | 186 | <120 |
ApoA1 (mg/dL) | 156 | 188 | |
Lp(a) (nmol/L) | 18 | 7 | <105 |
Glucose (mmol/L) | 4.3 | 5.0 | <6.0 |
Insulin (pmol/L) | 16.4 | 17.5 | 12–96 |
C-peptide (nmol/L) | 0.19 | 0.19 | 0.2–0.8 |
HOMA-IR | 0.5 | 0.6 | <2.0 |
FibroScan CAP (dB/m) | 185 | 185 | 156–288 |
FibroScan LSM (kPa) | 6.2 | 6.2 | <7 |
Liver fat content (%) | <2 | 2.7 | <5 |
Carotid IMT thickness (percentile) | >97th | 90th | Based on age and sex, according to [19] |